TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Individuals Enrolled and Number of Assessments and Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time Required for Screening and Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety as assessed by lab work and adverse event monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interpretable chemogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin action in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breast milk composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D binding protein binding characteristics (affinity constant)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self reported Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Drop Outs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dentin Phosphoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cervical passive range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Correct Positioning of Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of roots in maxillary premolars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Intracranial objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Disease-free survival at 4 years
Endpoint domain: Mortality/survival
Primary endpoint: Permanent neurological events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Circulating (serum) IL-10 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Single-leg peak isokinetic torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: BETY Biopsychosocial Questionnaire (BETY-BQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Canine Retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Weight (Lbs.) at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary pharmacokinetic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lead-related Complication-free Rate at 3 Months
Endpoint domain: Adverse events/effects
Primary endpoint: CRB-65 severity index distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-weighted Sum of Pain Intensity Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of vericiguat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCu of vericiguat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of vericiguat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax,u of vericiguat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in performance in episodic memory task (pictorial)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in performance in episodic memory task (verbal)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety of T Regulatory Cell Infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of T Regulatory Cell Infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants having Annual Spirometric Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time above Minimum Inhibitory Concentration (T > MIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mother's Accuracy in using Thermospot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of MDD Patients with Near Term Relapse
Endpoint domain: Mortality/survival
Primary endpoint: 4-hour C-peptide Area Under Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mouth Handicap in Systemic Sclerosis Questionnaire (MHISS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Chatting frequency
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Constant Rate Cycle Ergometry Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with high-risk pancreatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prediction of high risk areas for progressive glioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of anastomotic leak
Endpoint domain: Adverse events/effects
Primary endpoint: Pain at 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulsitality index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neutrophil gelatinase-associated lipocalin (NGAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: growth differentiation factor 15 (GDF-15)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Clinical Benefit (OCB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of iron and folic acid (IFA) syrup
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of micronutrient powders (MNP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vitamin supplementation compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Plasma Ammonia Area Under the Curve (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Ureagenesis Based On Presence of [1-13C] In Urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: relative cerebral blood volume (rCBV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: relative peak height (rPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of signal intensity recovery (PSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of ZD1839 in head and neck cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycemic Control by HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevention of Severe Hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Number of Drinks Consumed Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-Vi seropositivity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-HAV seropositivity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Imaging of brown adipose tissue (BAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Health promoting competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stability of fixed fractured segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay to surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Distribution of Comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety- Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage change in postprandial glucose AUC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intra-uterine pregnancy with fetal heart beat at 10 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Mean Pacing Capture Threshold (V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Pacing Impedance (Ohms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean R-Wave Amplitude (mV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % of R-R Intervals With Appropriate Pacing and Sensing During Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Participant ability to complete 75% or more of trial visits
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in knee bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum Severity of Post-operative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Post-operative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurence of Post-operative Nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of molecules in the glycine/serine pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Progression-free Survival (PFS6)
Endpoint domain: Mortality/survival
Primary endpoint: Change in ASD Symptoms as measured by SRS-2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with AF recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of condom protected vaginal sex acts
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Congruence between patient and surrogate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient and surrogate satisfaction with communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Canadian Cardiovascular Society (CCS) grading of angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Seattle angina questions (SAQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Freedom from Scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Average forced expiratory volume in one second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Patients with Smoking Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+ to CD8+ T Cell Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bacterial and antimicrobial susceptibility profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Aortic annulus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean number of drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: observable global change in the uptake of 18F-FLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of eggs retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: improvement of xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between BCB and TSB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient-reported Nasal Blockage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in binge/high-risk drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Self-Care Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot Care Confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Foot Care Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Pain and Disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting insulin/glucose ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fractional sodium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: p-vasopressin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: p-aldosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in ventilator days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients free from composite Major Adverse Events
Endpoint domain: Mortality/survival
Primary endpoint: Change in liver stiffness (kPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of splint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time consumed to apply and remove the splint
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Attendance of parent/caregivers at higher-level health facilities
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unified myoclonus rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Healing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of P50 auditory sensory gating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: T2*
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Toe-Brachial Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total five symptoms score (T5SS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in overall sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of adequate clinical and parasitological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Matsuda Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Adipose Tissue Insulin Resistance (Adipo-IR) Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of a mutated allele
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Severe Hypoglycemic Event - Cohort A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Diabetic Ketoacidosis (DKA) Event - Cohort A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Time in Euglycemia - Cohort A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of recurrent ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Best Response Following Extended Use of CS-7017
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Cells With Positive Staining for Apoptosis, Proliferation, Oxidation, and Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Energy and protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Experienced at Least One Adverse Event in Phase A
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Discontinued From the Study Drug Due to an Adverse Event in Phase A
Endpoint domain: Adverse events/effects
Primary endpoint: Change in catecholamines and glycerol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in proportion of energy source
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in electromyographic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspeptic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Community treatment admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Community treatment retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participation in HIV testing and counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: primary endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in globus symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Endoscopic eradication of inlet patch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Histological reversal to squamous mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in surface area of residual inlet patch post ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of PCV13 post-booster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response and Durability of Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Feasibility and Tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluate Immune Reconstitution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients with Reduction in Red Blood Cell Transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient Iron Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the concentration time curve (AUC) of ganciclovir in steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk Factor Reduction for Metabolic Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of Subjects Free From System-related Chronicle ICD Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of Subjects Free From Chronicle IHM System-related Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative Risk Reduction of All Heart Failure Related Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of DLTs at Each Dose Level
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of surgical interventions with communication failure
Endpoint domain: Adverse events/effects
Primary endpoint: Total Time Mechanically Ventilated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post operative Opioids consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in intramedullary vascular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: New bone growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parathyroid serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of passage of lower ureteric stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Inflammatory cellular infiltrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Greater Than or Equal to 50% Donor Chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neointimal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: presence of tumor cells in the operative field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pregnancy specific changes in hemodynamic variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Onset of atrial fibrillation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in clinico-biological signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image quality, as measured by image rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes